Discovery of <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity
Jinxin Che(Pharmaceutical Biotechnology (Czechia)), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University), Haichao Sheng(Zhejiang University), Zizheng Gao(Zhejiang University), Bo Yang(Tongde Hospital of Zhejiang Province), Jian Gao(Hebei Medical University), Qinjie Weng(ZheJiang Institute For Food and Drug Control), Peihua Luo(Zhejiang Lab), Zegao Jin(Zhejiang University), Wenhu Zhan(Cornell University), Dan Li(Zhejiang University), Yang Lu(Wuhan University), Qiaojun He(Zhejiang Lab), Yongzhou Hu(Zhejiang University), Xiaoyang Dai(Zhejiang Lab), Binhui Chen(Zhejiang University)
Cited by 23
Related Papers
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400
Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics
|Nature Communications|2021|297
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner
|Oncogene|2019|265